封面
市场调查报告书
商品编码
1741214

粪钙卫蛋白检测市场(依检测类型、适应症、最终用户和地区划分)

Fecal Calprotectin Test Market, By Assay Type, By Indication, By End User,, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格
简介目录

粪便钙卫蛋白检测市场规模预计在 2025 年达到 1.551 亿美元,预计到 2032 年将达到 3.494 亿美元,2025 年至 2032 年的复合年增长率为 12.3%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 1.551亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期 2025-2032 年复合年增长率: 12.30% 2032年价值预测 3.494亿美元

消化器官系统发炎是由慢性发炎性肠道疾病性肠道疾病(IBD) 引起的。肠道中的白血球会释放一种名为粪钙卫蛋白的蛋白质,这种蛋白质在 IBD 患者体内水平升高,因此是识别和追踪该疾病的有用生物标记。

市场动态:

预测期内,胃肠道疾病盛行率的上升、认知度的提高和早期检测的普及,以及非侵入性和便捷的检测方式,预计将推动全球粪便钙卫蛋白检测市场的成长。此外,医疗保健机构的日益普及也有望推动全球粪钙卫蛋白检测市场的成长。新兴市场的整合、就地检验、家用检测套组以及数位健康技术的应用,预计将为全球粪便钙卫蛋白检测市场创造成长机会。

然而,预计在预测期内,有限的报销范围、成本敏感性、测试结果的多变性以及有限的意识和医生知识将阻碍全球粪便钙卫蛋白检测市场的成长。

本研究的主要特点

  • 本报告对全球粪便钙卫蛋白检测市场进行了详细分析,并提供了预测期 2025-2032 的市场规模和复合年增长率(以 2024 年为基准年)。
  • 它还强调了各个领域的潜在商机,并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、绩效和策略等参数,介绍了全球粪钙卫蛋白检测市场的主要企业概况。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 本研究报告针对该产业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球粪便钙卫蛋白检测市场的各种策略矩阵来促进他们的决策。

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 胃肠道疾病盛行率不断上升
    • 粪便钙卫蛋白检测的报销可能有限
    • 与数位健康科技的整合
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章 冠状病毒(COVID-19)疫情的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 依检测类型,2020-2032

  • 酵素免疫分析法(ELISA)
  • 酵素萤光免疫分析法
  • 定量层析法

第六章. 依适应症,2020-2032

  • 发炎性肠道疾病肠道疾病(IBD)的诊断
  • 大肠直肠癌
  • 乳糜泻
  • 其他的

第 7 章. 依最终使用者划分,2020-2032 年

  • 医院
  • 诊断实验室
  • 学术研究所
  • 其他的

第八章. 按地区,2020-2032 年

  • 北美洲
      • 美国
      • 加拿大
  • 欧洲
      • 德国
      • 英国
      • 法国
      • 西班牙
      • 义大利
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 中东和非洲
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第九章 竞争态势

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Abbexa Limited
  • Bioserv Diagnostics Gmbh
  • Epitope Diagnostics, Inc.
  • LifeSpan BioSciences, Inc.
  • RayBiotech, Inc.
  • ALPCO

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5952

Fecal Calprotectin Test Market is estimated to be valued at USD 155.1 Mn in 2025 and is expected to reach USD 349.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 155.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.30% 2032 Value Projection: USD 349.4 Mn

Inflammation of the digestive system is brought on by the chronic illness of Inflammatory bowel disease (IBD). White blood cells in the intestines release a protein called fecal calprotectin. It is high in IBD patients, making it a helpful biomarker for identifying and tracking the condition.

Market Dynamics:

The increasing prevalence of gastrointestinal disorders, growing awareness and early detection, and non-invasive and convenient testing are anticipated to drive growth of the global fecal calprotectin test market over the forecast period. Moreover, increasing adoption by healthcare providers is also expected to boost growth of the global fecal calprotectin test market over the forecast period. Emerging markets, point-of-care testing, home-based testing kits, and integration with digital health technology options are expected to create growth opportunities for the global fecal calprotectin test market during the forecast period.

However, limited reimbursement coverage, cost considerations, variability in test results, and limited awareness and physician knowledge are expected to hamper growth of the global fecal calprotectin test market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global fecal calprotectin test market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global fecal calprotectin test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbexa Limited, Bioserv Diagnostics Gmbh, Epitope Diagnostics, Inc., LifeSpan BioSciences, Inc., RayBiotech, Inc., ALPCO
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global fecal calprotectin test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders have ease in decision-making through various strategy matrices used in analyzing the would global fecal calprotectin test market

Detailed Segmentation:

  • By Assay Type:
    • Enzyme Linked Immunosorbent Assay (ELISA)
    • Enzyme Fluoroimmunoassay
    • Quantitative Immune-Chromatography
  • By Indication:
    • Inflammatory Bowel Disease (IBD) Diagnosis
    • Colorectal Cancer
    • Celiac Disease
    • Others
  • By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Academic and Research Institutes
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Becton, Dickinson and Company
    • Abbexa Limited
    • Bioserv Diagnostics Gmbh
    • Epitope Diagnostics, Inc.
    • LifeSpan BioSciences, Inc.
    • RayBiotech, Inc.
    • ALPCO

Table of Content

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market global fecal calprotectin test, By Assay Type
    • Market global fecal calprotectin test, By Indication
    • Market global fecal calprotectin test, By End User
    • Market global fecal calprotectin test, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of gastrointestinal disorders
    • Rreimbursement coverage for Fecal Calprotectin Tests may be limited
    • Integration with digital health technologies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Fecal Calprotectin Test Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Fecal Calprotectin Test Market, By Assay Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Enzyme Linked Immunosorbent Assay (ELISA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Enzyme Fluoroimmunoassay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Quantitative Immune-Chromatography
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Fecal Calprotectin Test Market, By Indication, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Inflammatory Bowel Disease (IBD) Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Colorectal Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Celiac Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

7. Global Fecal Calprotectin Test Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

8. Global Fecal Calprotectin Test Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Germany
      • U.K.
      • France
      • Spain
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbexa Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bioserv Diagnostics Gmbh
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Epitope Diagnostics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LifeSpan BioSciences, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • RayBiotech, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • ALPCO
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us